The FDA approved TREGZI, the first regulatory T-cell…

The FDA approved TREGZI, the first regulatory T-cell immunotherapy to prevent chronic graft-versus-host disease A bone-marrow transplant can cure the cancer and then be undone by the donated immune system attacking the patient.